EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Confirmatory Validation and Cluster Classification of the Irritable Bowel Syndrome Symptom Severity Scale

Pragalathan Apputhurai, Olafur S Palsson, Shrikant I Bangdiwala, Ami D Sperber, Antonina Mikocka-Walus, Simon R Knowles

Value in Health · 2026-09

DOI: 10.1016/j.jval.2026.08.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2026-09. Verfasst von Pragalathan Apputhurai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Health and Exercise Sciences, School of Health Sciences, Swinburne University of Technology, Melbourne, Australia. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Takeda Pharmaceuticals USA Inc, Ironwood Pharmaceuticals Inc, Shire Pharmaceuticals Lexington.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Irritable bowel syndrome (IBS) affects about 4% of the global population and is associated with high psychological distress. The IBS Symptom Severity Scale (IBS-SSS) is the most widely used patient-reported outcome measure for IBS, but its psychometric properties are understudied. Using the largest and most globally representative IBS sample, this study provides a comprehensive psychometric evaluation of the IBS-SSS. The aim of this study is to examine the factor structure of the IBS-SSS and identify symptom profiles using the Rome IV Global Epidemiology Survey. METHODS: A cross-sectional sample of individuals with IBS (N = 1512) completed the IBS-SSS. Confirmatory factor analyses compared 1- and 2-factor models across the total sample, IBS subtypes, and IBS status (with vs without additional Disorders of Gut-Brain Interaction). Latent profile analyses identified symptom profiles, and their associations with IBS subtypes were examined. Multivariate analysis of variance was used to test differences in IBS-SSS domains across profiles. RESULTS: A 2-factor model showed the best fit. Three profiles were identified: high (12.5%), moderate (42.7%), and low severity (44.8%). Profile membership showed weak associations with IBS subtypes, whereas IBS subtypes differed strongly across symptom domains (Wilks' Λ = 0.02, P < .001, partial η2 = 0.98). Receiver operating characteristic analysis supported severity cut-offs based on the total IBS-SSS score (≤274: mild, 275-354: moderate, and ≥355: severe) with 83% accuracy. CONCLUSIONS: The IBS-SSS demonstrates strong psychometric validity and effectively distinguishes symptom severity. The findings highlight the heterogeneity of IBS and support symptom-based, personalized approaches over subtype-based classification.

Schlagwörter

Stichwörter der Autor:innen

confirmatory factor analysisirritable bowel syndromelatent profile analysissymptom severity

Autor:innen und Institutionen

  • Department of Biomedical Health and Exercise Sciences, School of Health Sciences, Swinburne University of Technology, Melbourne, Australia.
  • Center for Functional GI and Motility Disorders, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
  • Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • School of Psychology, Deakin University, Burwood, VIC, Australia.
  • Department of Biomedical Health and Exercise Sciences, School of Health Sciences, Swinburne University of Technology, Melbourne, Australia; Department of Psychological Sciences, School of Health Sciences, Swinburne Univ…

Förderung

  • Takeda Pharmaceuticals USA Inc
  • Ironwood Pharmaceuticals Inc
  • Shire Pharmaceuticals Lexington
  • Allergan US

Zitieren

APA

Apputhurai, P., Palsson, O. S., Bangdiwala, S. I., Sperber, A. D., Mikocka-Walus, A., & Knowles, S. R. (2026). Confirmatory Validation and Cluster Classification of the Irritable Bowel Syndrome Symptom Severity Scale. Value in Health. https://doi.org/10.1016/j.jval.2026.08.010

Vancouver

Apputhurai P, Palsson OS, Bangdiwala SI, Sperber AD, Mikocka-Walus A, Knowles SR. Confirmatory Validation and Cluster Classification of the Irritable Bowel Syndrome Symptom Severity Scale. Value in Health. 2026. doi:10.1016/j.jval.2026.08.010

BibTeX
@article{Apputhurai2026,
  author = {Apputhurai, Pragalathan and Palsson, Olafur S and Bangdiwala, Shrikant I and Sperber, Ami D and Mikocka-Walus, Antonina and Knowles, Simon R},
  title = {Confirmatory Validation and Cluster Classification of the Irritable Bowel Syndrome Symptom Severity Scale},
  journal = {Value in Health},
  year = {2026},
  doi = {10.1016/j.jval.2026.08.010}
}
Kostenlos starten →